Study identifies how to improve WHO eradication strategy for skin disease

February 8, 2018, Walter and Eliza Hall Institute
Alyssa Barry. Credit: Walter and Eliza Hall Institute

An international research collaboration published in The Lancet has found crucial evidence that could help to improve the current World Health Organization (WHO) strategy to eradicate yaws—a chronic disfiguring and debilitating infectious disease affecting the skin, bones and joints.

Despite efforts the elimination of yaws in a high-endemic community in Papua New Guinea (PNG) is yet to be achieved. The research identifies relapsing, untreated infections and the emergence of antibiotic resistance as contributing to ongoing yaws infection in the community. Researchers from Spain, PNG, US, Australia, and international colleagues led the study.

Yaws is caused by Treponema pallidum, a subspecies of the bacterium that causes syphilis. It is spread by direct contact through minor injuries such as cuts and scratches on the skin and afflicts mostly children. It initially causes painful skin lesions but, if left untreated, can lead to chronic deformities and disability.

Yaws is an ideal candidate for eradication because it is only found in humans and is easily treated by antibiotic treatment.

WHO's current strategy to eradicate yaws by 2020 involves a single round of mass treatment with the inexpensive antibiotic azithromycin, followed by targeted treatment programs every 3-6 months to identify and treat all symptomatic cases and their contacts.

Australian infectious diseases geneticist and study contributor Associate Professor Alyssa Barry from the Walter and Eliza Hall Institute said the research suggested adapting the WHO approach in three key areas to speed up yaws eradication efforts.

"The findings point to a need for multiple rounds of mass drug administration in order to capture those not present during the first round," Associate Professor Barry said.

"Research also showed a much bigger geographical area should be targeted for the mass treatment, in order to protect against the migration of infection in people from surrounding communities. Finally, there is a clear need for ongoing monitoring to prevent the spread of drug-resistant strains, following world-first evidence of antibiotic resistance in yaws bacteria," she said.

Dr Oriol Mitjá from the International SOS Lihir Medical Centre, PNG, and the Barcelona Institute for Global Health, Spain, said the findings suggested a single round of mass treatment with azithromycin was insufficient to eradicate yaws.

"Our findings highlight the importance of treating every person in a community to be sure of targeting all latent infections. Doing multiple rounds of mass treatment may be necessary to eliminate yaws," Dr Mitjá said.

Associate Professor Barry said the forensic precision of modern genetic and genomic analysis was an essential tool in the fight towards infectious disease control and elimination.

"DNA-based tests following the WHO's mass drug administration showed a reduction in yaws strain diversity and a decrease in transmission of the disease. This is a sound indication that the mass treatment of azithromycin is an effective option.

"Further testing detected new strains that were not local but imported by visitors to the island. These data supported the recommendation for multiple rounds of mass drug administration and that efforts to eradicate yaws should target a broader geographic area," she said.

The study is a wonderful demonstration of how basic research can be translated to have a significant influence on global disease eradication policy and programs, said Associate Professor Barry.

"It's great to see the PNG study's findings could have an impact on the global eradication of yaws," she said.

Explore further: Expert urges action to eradicate yaws, tropical disease

Related Stories

Expert urges action to eradicate yaws, tropical disease

March 19, 2015
Half a century ago, a concentrated global effort nearly wiped a disfiguring tropical disease from the face of the earth. Now, says Case Western Reserve's James W. Kazura, MD, it's time to complete the work.

Why treating animals may be important in fighting resurgent tropical disease

April 12, 2017
As the World Health Organization steps up its efforts to eradicate a once-rampant tropical disease, a University of Washington study suggests that monitoring, and potentially treating, the monkeys that co-exist with humans ...

Re-emergence of syphilis traced to pandemic strain cluster

December 5, 2016
Over the last few decades, an age-old infectious disease has been re-emerging globally: syphilis. Using techniques to analyze low levels of DNA, an international research team headed by the University of Zurich has now shown ...

WHO urges billions to fight neglected tropical diseases

February 19, 2015
The World Health Organization on Thursday urged countries to invest billions of dollars to tackle 17 neglected tropical diseases—including dengue fever, leprosy and sleeping sickness—which kill 500,000 people globally ...

Study raises concerns about drug-resistant STI

September 5, 2017
Greater understanding of testing and treatment is needed to mitigate the rapid increase in drug resistance of a common sexually transmitted infection (STI), according to a study by the University of Bristol, published in ...

Recommended for you

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.